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Many of the molecules identified on the surface of both bone marrow-derived (B) 1 
and thymus-derived (T) lymphocytes can be displaced from their original position 
on the surface membrane after reaction with one or more ligands. The displaced mole- 
cules can form multiple complexes  on the membrane or can agglutinate into a single 
compact mass at one pole of the cell,  the  cap.  For  example, the  surface  immuno- 
globulin (Ig) on murine B  lymphocytes usually agglutinates in a  cap upon reaction 
with anti-Ig (1, 2) or specific multivalent antigen (1, 3). Other surface molecules such 
as the antigens that react with heterologous antilymphocyte antibodies (2), the con- 
canavalin A  (Con A)  receptors  (2),  histocompatibility antigens (4),  and the  theta 
isoantigen (1) are also redistributed after reaction with appropriate ligands. 
Several factors  in the ligand-induced movement of surface molecules have been 
analyzed in previous studies (1, 2, 4, 5). (Usually the movement was ascertained micro- 
scopically by determining with appropriate markers whether caps formed on the sur- 
face membrane.) It was found that the movement of complexed surface molecules was 
dependent on: 
(a)  Temperature. No cap formation took place at 4°C, but caps readily developed 
at 37°C  (1, 2). 
(b)  A cross-linking ligand. Caps developed with bivalent antibodies, but not with 
monovalent antibodies (1, 2). 
(c)  Amounts of ligand. Caps developed only when antibody cross-linked most of 
the surface molecules, presumably into a single lattice; lower concentrations of anti- 
body led  to  small, disseminated complexes  that  were  interiorized by the  cell,  but 
that did not agglutinate into a single mass on the membrane (2). 
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(d)  The  geographic  disposition  of  the  surface  molecules.  The  distances  between 
molecules varied and apparently determined whether cap formation would occur after 
direct or sandwich reaction, i.e., molecules close enough to be linked within the span 
of the combining sites of the ligand  (usually  an  antibody:  120 fi~) readily led to caps 
(i.e.,  Ig and  Con A  sites)  whereas  those  farther  apart  did  not yield  caps  unless  an 
antibo@ to the ligand was brought into the reaction (total theoretical span of an anti- 
body on another antibody is 420 A)  (2, 5, 6). 
Another point to emerge from our own previous studies  relates to  the association 
between  the formation of complexes with the surface molecule and  the process of in- 
teriorization  (2,  5).  Clearly no  association  was  evident between  complex  formation 
with or without  capping,  and  endocytosis. Although complexes of anti-Ig-membrane 
Ig were interiorized (regardless of whether or not capping occurred), complexes formed 
with antilymphocyte antibodies (bivalent or monovalent)  or with antibodies to histo- 
compatibility  antigens  were  interiorized  slowly.  Moreover,  caps  formed  with  anti- 
lymphocyte antibodies  (in a  sandwich-type reaction)  were not interiorized within the 
period of several hours.  These results  suggested  to us that  there were a  rapid and  a 
slow form of endocytosis. Rapid endocytosis was conditioned not only by the property 
of the ligand to cross-link the surface molecule but also by the geographic disposition 
of the molecules on the membrane.  Slow endocytosis was not related  to cross-linking 
of membrane determinants. 
In  the  present  paper  we  report  studies  on  the  relationship  of  viability  and 
metabolic activity of the lymphocytes to both surface movement and interiori- 
zation  of  Ig,  anti-Ig being  used  as  the  ligand.  Movement  was  ascertained  by 
microscopic examination of cells exposed to fluorescein-tagged  (FITC)  anti-Ig. 
Interiorization  was  determined  in  part  by  ultramicroscopic  examination, 
but  mainly  by  determining  whether  the  anti-Ig  labeled  with  radioiodine  was 
degraded.  Previous studies have shown  that  the interiorized anti-Ig is partially 
degraded  by  lymphocyte  hydrolases  (7). 
Materials  and  Methods 
Cells.  Cells  were harvested  from spleens  of  A/St mice  by  conventional methods  using 
Eagle's minimal essential medium  (Grand Island Biological Co.,  Grand Island,  N. Y.)  with 
10% fetal calf serum.  The mice, 8-12 wk old, of either sex, were obtained from West Seneca 
Labs,  Buffalo,  N.  Y.  In  most  experiments  the  cells  were centrifuged  on  a  Fieoll-Hypaque 
gradient in order to separate the live cells from dead cells, erythrocytes, and debris (8). After 
centrifugation  the live cells  (>99°7o  viable) were washed  three  times and  were used  in the 
various experiments. 
Eifects o[ Drugs  on Movement of Anti-Ig-Surface Ig Complexes.--The spleen  cells at a con- 
centration  of 5  >(  106, usually in 100-200/zl of medium, were first incubated with the drugs 
(in  100/zl)  for various periods of time, usually 10-30  rain at room temperature. The cell sus- 
pension was then placed in au ice bath at 4°C and incubated with 10 Izg of fluorescein-conju- 
gated  rabbit  antimouse  Ig  (FITC-RAMG)  for 30  min.  The cells  wete spun,  washed  three 
times,  resuspended  in  about  500/zl of medium, placed in a  37°C  incubator  (containing 5% 
CO2 in air), and examined for periods of up to 6 h (in most experiments the cells were examined 
at 5,  10, and 20 min after warming). The movement of the surface complexes was evidenced 
by the formation of the cap, i.e. the concentration of the fluorescence  reaction at  one pole of 
the cell, usually in an area encompassing a third of the cell surface.  In our hands, cap forma- E.  R.  UNANUE,  M.  J.  KARNOVSKY~ AND  It.  D.  ENGERS  677 
tion on mouse B lymphocytes is very rapid in that about 80-95% of fluorescent spleen lympho- 
cytes cap after 1-5 rain incubation at 37°C.  (About 45-50% of spleen lymphocytes have sur- 
face Ig detectable by FITC-RAMG.) 
The anti-Ig used in these experiments was polyvalent and precipitated with all mouse Ig 
and with Fab determinants. It was the same anti-Ig employed in the experiments reported 
previously, for which specificity controls have been fully detailed (2, 5, 9). 
The following drugs were employed : Na azide, dinitrophenol (Eastman Chemical Products, 
Inc., Rochester, N. Y.; it was recrystallized twice with ethanol and resuspended in phosphate 
saline at pH 7.2),  oligomycin (Sigma Chemical Co., St. Louis, Mo.), NaCN,  NaF, iodoacet- 
arnide,  2-deoxyglucose,  cytochalasin B  (ICI  Research Lab,  Cheshire, England), colchicine, 
dibutyril cyclic AMP  (cAMP), actinomycin D, cycloheximide, and puromycin  (the last five 
drugs were obtained from Sigma Chemical Co.). All solutions of drugs were freshly prepared 
and used immediately. 
Effects of Drugs on the Cata}olism of [125IJA  nti-Ig by B Lymphocytes.--Previous  studies indi- 
cated that the complexes of anti-Ig-surface Ig on B  lymphocytes were readily interiorized in 
small vesicles (2, 5)  and that once interiorized, the anti-Ig was partially degraded by the B 
lymphocytes  (7).  The process of interiorization and degradation was tested by labeling the 
anti-Ig molecule with 125I and following the fate of the label after binding of the antibody to 
the surface of the B  lymphocyte. In the present experiments, the influence of various drugs 
on  the  catabolism  of  [125I]anti-Ig was  investigated.  The  rabbit  IgG  with  anti-Ig activity, 
RAMG, xvas labeled with 125I ([125I]RAMG) by the lactoperoxidase method  (10)  to a specific 
activity of 1/zCi//zg. In all experiments 20 #g of [12~I]RAMG were incubated with 107 spleen 
cells at 4°C for 30 rain, after which the cells were washed five times, resuspended in 1 ml of 
medium,  and placed in culture  1-6 h. At these times,  the supernatant fluid was  separated 
from the cells by centrifugation. The cell pellets were lysed in 1 ml of 0.5% (IGEPAL CA-630, 
a polyethyleneoxy derivative) (GAF Corporation, New York) in phosphate-buffered saline at 
room temperature for 15 rain. The intact nuclei were removed by centrffugation at 1,500 g for 
20 min. Samples of the culture supernatants and cell-associated samples were tested for total 
radioactivity and were precipitated in 12% TCA. Hence radioactivity was measured in super- 
natants and cell-associated fractions as precipitated, protein-bound a25I, and not precipitated, 
non-protein-bound 125I. 
As in the previous experiments, the cells were incubated with drugs for various peliods  of 
time before and after the reaction with [125I]RAMG. The spleen cells used in these experiments 
were incubated on plastic dishes in order to remove macrophages before testing  with [125][]_ 
RAMG: 3  X  107 spleen cells  (after centrifugation through a  FicolI-Hypaque gradient),  in 3 
ml, were incubated on 50 x 25 mm dishes (Falcon Plastics, Oxnard, Calif.)  for 1 h  at 37°C. 
The cells that did not attach were incubated on dishes for a  second  period of 1 h. Further 
details on these procedures have been given in reference 7. 
Ultrastructural Analysis  ofB Lymphocytes.--Ultrastructural  studies were done on spleen ]3 
lymphocytes treated with metabolic inhibitors at 4°C, then incubated with ferritin-conjugated 
RAMG, washed, and then incubated at 4 or 37°C for various periods of time. The distribution 
on the surface of the anti-Ig-Ig complexes was studied by freeze-etching methods,  previously 
described in detail (5).  Conventional thin section studies were also done. The ferritin-conju- 
gated RAMG was the same used in our previous study  (5); the ratio of fe~ritin to Ig was 0.5; 
the dose of conjugate was 20 #g/107 spleen cells. 
RESULTS 
Cap  Formation 
Effects  of Metabolic Inhibitors.--Table  I  summarizes a  series of experiments 
in which different inhibitors, at different doses,  were used.  Inhibitors of oxida- 678  MOVEMENT  O~F  SURFACE  ANTIGENS.  III 
tive  phosphorylation  and  of  glycolysis  inhibited  the  movement  of  surface  Ig 
molecules into a  cap.  In most of the experiments the cells were incubated with 
the inhibitors for  10 min, washed,  incubated with FITC-RAMG,  and warmed. 
TABLE  I 
Drugs That Inhibit Capping 
Drug  Dose  Inhibition of capping 
Na azide 
Dinitrophenol 
Oligomycin 
% 
3  X  IO-SM  0 
10  -2 M  50 
10  -i M  100" 
5  X  10  -3 M  90-95* 
5  X  10  -4 M  32 
5  )<  IO-SM  0 
100 ~g  100 
10 #g  100 
1 #g  100 
NaCN  10  -~ M  100 
10  -4 M  37-80 
NaF  10  -2 M  15 
10  -3 M  0 
Iodoacetamide 
2-Deoxyglucose 
10  -2 M  100 
5  X  10  -3 M  97-100 
10  -3 .~I  40-65 
10  -2 M  30-50-59 
10  -~ M  0 
10  -4 M  0 
This table  summarizes several different experiments.  Cell death in all experiments was 
about  5%.  Groups marked  with  * denote cell death in the range  of about  25%.  Usually 
45-50%  of spleen cells were positive for anti-Ig, and of these about 80-95%  capped  after 
warming for 10 rain at 37°C.  Each figure represents the results of one experiment. All drugs 
except  2-deoxyglucose  were incubated for  10 rain  at  room  temperature before addition  of 
FITC-RAMG.  Cells were  incubated with 2-deoxyglucose in saline for 30 rain  before incu- 
bation with FITC-RAMG; incubation at 37°C also took place with cells suspended in phos- 
phate-buffered saline. 
Cells  were  examined  for  periods  of  up  to  6  h.  The  pattern  of  fluorescence  in 
the  inhibited cells changed from a  finely linear reticulated  type  pattern  when 
examined  at  4°C  to  a  coarse  pattern,  occasionally  with  a  beady"  appearance, 
after  several  hours  at  37°C  in  presence  of  the  inhibitors.  (The  presence  or E.  R.  UNANUE,  l~.  J.  KARNOVSKY,  AND  It.  D.  ENGERS  679 
absence of the inhibitor during the incubation at 37°C did not influence the re- 
sults.) The appearance suggested a  coarser accentuation of the original pattern 
of distribution. 
TABLE II 
Drugs That Did Not Affect Capping 
Drug  Dose  Inhibition of capping 
% 
Cytochalasin B  10/zg  0 
30 #g  23* 
60/zg  30* 
Colchicine  10 #g  0 
50 #g  0 
100 #g  0 
Actinomycin D  0.5 #g  0 
5.0 #g  0 
Puromycin  0.1 #g  0 
0.5 #g  0 
Cycloheximide  0.2 #g  0 
0.4 #g  0 
cAMP  10  -4 M  0 
10  -6 M  0 
10  -s M  0 
EDTA  0.01  M  0 
This table summarizes  several different  experiments.  Cell death in all experiments was 
about 5%.  Groups  marked with * denote cell death in the range of about 25%.  Usually 
45-50%  of spleen cells were positive for anti-Ig, and of these about 80-95% capped after 
warming for 10 rain at 37°C. Lymphocytes were incubated with actinomycin D, puromycin, 
or eycloheximide for 2 h before reaction with FITC-RAMG. With the remaining drugs, the 
lymphocytes were just incubated for 10 min. 
In  all the  experiments reported in Table I,  the  cells were  checked for via- 
bility by the trypan blue exclusion test. With some concentrations of inhibitors, 
cell viability was  impaired.  In  these  cases high  cell mortality could  account 
for the inhibitory effects (i.e., azide at 10  -1 M,  dinitrophenol at 5  X  10  -8 M). 
Indeed,  other  experiments  clearly established  that  dead  lymphocytes  would 
not develop cap formation: for example, in one experiment we tested, for cap- 
ping  of  anti-Ig,  lymphocytes  that  had  been  incubated  with  FITC-RAMG, 
washed,  and  then  incubated  for  18  h  in  phosphate-buffered  saline  at  4°C. 
After 18  h  most cells were dead and did not cap upon  warming.  In contrast, 680  MOVE~'IENT  OF  SIYRFACE ANTIGENS.  III 
the  control  group  lymphocytes  incubated  overnight  in  medium  were  viable 
and readily developed  caps after warming  at 37°C.  Other,  more drastic meth- 
ods  for  killing,  such  as incubation in  0.001%  merthiolate,  also  led  to  similar 
effects. 
E2yect of Inhibitors  of Protein Synthesis.--lO  million  spleen  cells were  incu- 
bated  for  2  h  at 37°C  in  1  ml of medium  containing actinomycin D  (0.02-5.0 
#g),  puromycin  (0.1  and  0.5  #g),  and  cycloheximide  (0.2  and  0.4  pg),  after 
TABLE  III 
Effects of Drugs on Catabolism of [125I]Anti-Ig 
Culture SUl~eraatants  Cell-associated 
Total t25I  PB-l-~sI  NPB-l~I  Total 12~I  PB-1~zI  NPB-I~I 
%  % 
Control 
37°C  (3)  32.5  10.4  22.1  67.5  41.7  25,8 
0QC  (2)  2.8  2.5  0.3  97.2  94.2  3.0 
Iodoacetamide 
10  -~ M  (2)  11,4  11.1  0.3  88.6  83.3  5.3 
10-4M  (I)  18,9  11.7  7.2  81.1  57.1  24.0 
10-SM  (1)  29.l  11.1  18.0  70.9  38.0  32.9 
Dinitrophenol 
5 X  10  -3 M  (1)  13.0  11.4  1.6  87.0  73.6  13,4 
5 X  10  -4 M  (1)  30.0  12.6  17.4  70.0  39.4  30.6 
5 X  10  -5 M  (1)  31.0  12.1  17.9  69.0  38,0  31.0 
NaCN 
10  -~ M  (1)  12.5  11.0  1,5  87.5  75.2  12.3 
Oligomycin 
2 #g/ml (i)  15.4  12.9  2.5  84.6  74.5  10.1 
10 ~g/ml (1)  15.6  14.0  1.6  84.4  ND  ND 
Cycloheximide 
0.4#g  (1)  43.0  8.9  34.1  57.0  51.9  5.1 
Cytochalasin B 
10 ~g in 10/zl of DMSO  23.1  9.5  13.6  76.9  44.8  32.1 
~1) 
10/~1 of DMSO; no cyto-  24.9  8.4  16.5  75.1  42.8  32.3 
ehalasln B  (1) 
Colchicine 
100#g  (1)  19.2  9.2  10.0  80.8  41.3  39,5 
2-Deoxyglucose 
10  -~ M  (1)  35.6  11.7  23.9  64,4  39.3  25.1 
107  nonadherent spleen  ceils incubated with 20  #g  [125I]RAMG  in  the presence of  in- 
hibitor for 30 min at 4°C, washed five times, and then cultured for 120 rain at 37°C in the 
absence of inhibitor. ND  =  not tested. Figures represent the percent distribution after 2 h of 
the 125I bound after 30 rain of incubation at 4°C. PBJ 25I:125I radioactivity precipitated in 
12%  TCA;  NPB-12'sI:~2~I radioactivity  soluble  in  12%  TCA.  Figures  in  parentheses  in 
column 1 represent number of experiments. When more than one experiment was done, the 
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which  the), were incubated with FITC-RAMG at 4°C,  washed,  and warmed. 
There was no inhibition of cap formation at the doses used (see Table II). 
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FIG.  1 a.  The release of total radioactivity  during the 4.5-h period of incubation.  100~o 
radioactivity is that bound to the cells after 30 rain of incubation with [l'25IJRAMG  at 4°C. 
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FIG.  1 b. the release of radioactivity soluble in TCA. 100% radioactivity is that bound 
to the cells after 30 min of incubation with [m~I]RAMG  at 4°C. 
Effects of Cytochalasin B  and Colchicine.--Spleen  cells (5  X  106) were incu- 
bated first with 10, 30, and 60 #g of cytochalasin B in 100 #l for 15 rain; FITC- 
RAMG was  added  to  the  tube,  and the  ceils were  incubated for  ]/,~ h,  after 
which  they  were  washed  three  times in medium containing the  appropriate 
amount of cytochalasin B. Control cells were treated with appropriate concen- 682 E.  R.  UNANUE,  M.  J.  KARNOVSKY~  AND  H.  D.  ENGERS  683 
trations of dimethyl sulfoxide (DMSO). At concentrations of 30 and 60 ~g/ml 
there  was  some  inhibition  of  capping  (23  and  30%,  respectively).  At  these 
concentrations  many  cells  appeared  enlarged  and  swollen,  and  about  25% 
of them  were dead.  At  a  concentration  of  10 #g  there  was no  inhibition  of 
capping. 
Two  different  batches  of  cytochalasin  were  tested,  with  identical  results. 
Both batches appeared to be active since they were effective in altering some 
macrophage functions. To test the drug,  1 million macrophages harvested from 
the peritoneal cavity of mice that had received an intraperitoneal  injection of 
0.5  ml of 10% proteose peptone  (Difco Laboratories,  Inc., Detroit,  Mich.)  3 
days previously, were planted  in  Leighton  tubes in  1 ml of medium for 2  h. 
At that time the macrophages were well spread on the glass. 1 ~g of cytochalasin 
B  added  to  the  culture  rapidly reversed  the  spreading  and  caused  the  cells 
to round up.  This effect was rapidly reversible by replacing the medium con- 
taining  the  drug with fresh medium. 
In other experiments, which will be detailed in the future, such macrophages 
did not phagocytose sheep erythrocytes opsonized with rabbit antierythrocyte 
antibodies,  although  they did pinocytose radioactive proteins  such  as hemo- 
cyanin.  2 
Colchicine at a concentration of up to 100 #g did not reduce the formation of 
caps.  (For these results,  see Table II.) 
Other Treatment.--Cap  formation was not  affected by cAMP  at concentra- 
tions of 10--4-10  -s, or by EDTA at 0.01  M. (See Table II.) 
Catabolism of [I~5I]RA  MG 
Table IiI summarizes the results of several experiments. Usually in 2 h  the 
spleen  lymphocytes  released  26-42%  of  the  amount  of  12~I bound  initially 
(i.e.,  just  after incubation  at 4°C).  63-80%  of  this  released  ~2~I was not pre- 
cipitable in TCA.  (It was previously shown  that  the  radioactivity soluble in 
TCA represents 12~I bound to amino acids and peptides [7]. The protein-bound 
I~I  released  early  in  culture  includes  monomeric  Ig,  partially  degraded  Ig, 
and  ]g probably complexed  to  surface  Ig  [about  ~.6  of  total  protein  bound 
released]  [7].)  On  the other  hand  after 2  h  of incubation at  37°C,  one-fourth 
2 Unanue, E. R., and M. J. Karnovsky. UnpuNished experiments. 
FIo. 2.  Freeze-etched preparation of a mouse B lymphocyte treated with ferritin-labeled 
rabbit antimouse Ig for 30 rain at 4°C in the presence of iodoacetamide. The label is randomly 
distributed on the cell surface in the form of small, closely approximated patches. )< 45,000 
FIG. 3.  Similar to Fig. 2, except the cells were incubated with ferritin-labeled rabbit anti- 
mouse immunoglobulin for 4 h at 4°C. There is clumping of the label into slightly larger 
patches as compared with Fig. 2. )< 45,000 684  MOVEMENT  Ot  ~  SURFACE  ANTIGENS.  III 
FIo.  4.  Similar to Fig. 2, except the cells were incubated with ferfitin-labeled rabbit  anti- 
mouse immunoglobulin for 30 min at 4°C, washed, and then incubated at 37°C for 4 h. There 
is marked clumping of the label into large aggregates, leaving broad expanses of bare, unlabeled 
membrane. X  45,000 ?IG,  5.  Similar to Fig. 4. 
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to  one-half  of  the  cell-associated 12~I did  not precipitate  in  TCA.  Note  that 
iodoacetamide,  NaCN,  dinitrophenol,  and  oligomycin  readily  inhibited  the 
degradation of [~25I]RAMG. On the other hand, cycloheximide, cytochalasin B, 
colchicine,  and  2-deoxyglucose did not impair the process. 
Figs.  1 a  and  1 b  show  the  results  of one  experiment in  which  the  spleen 
ceils with bound [I~'~I]RAMG were cultured for l, 3,  and 41/~ h after treatment 
with oligomycin and iodoacetamide. The figures show the release of ~5I in the 
culture  fluids.  The  inhibition  of  the  catabolism  of  [mI]RAMG  during  this 
entire period is clearly demonstrated. 
Ullrastruclural Analysis 
30 million spleen ceils were incubated  with 5  X  10  -3  M  iodoacetamide for 
10 min at 37°C,  then washed  and  resuspended  in 400  /zl  containing  80 pg of 
ferritin-conjugated  RAMG.  After  ~/~  h,  the  cells were washed  and  incubated 
at 37°C  for 30 rain  and for 4  h.  Also,  samples of cells treated with  the drug 
were maintained  at 4°C  for 4 h. 
The pattern of distribution by freeze-etching methods of ferritin-RAMG on 
iodoacetamide-treated  B  lymphocytes after  30  rain  at  4°C  was  the  same  as 
detailed  before;  it  consisted  of  a  fine,  random  network  of  mostly intercon- 
nected  patches  over the  entire  surface  of the  ceils  (Fig.  2).  Cells  that  were 
incubated  at  4°C  for 4  h  showed,  at  the  most,  a  slight  accentuation  of  the 
patches,  i.e.,  no high  degree of aggregation  took place at 4°C  within  the 4-h 
period  (Fig.  3).  Cells  incubated  with  iodoacetamide for 4  h  at  37°C  showed 
the  presence  of molecules  on  the  surface.  These  were  distributed  again  in  a 
random pattern,  but now  in  the form of coarse networks consisting  of large, 
patchy aggregates (Figs. 4,  5).  Considerable expanses of bare membrane were 
observed between the labeled areas. (The results on cells not treated with the 
drug were reported in our previous study [5, 6]; normal untreated cells showed 
concentration of the molecules in one pole  [cap formation] within  the first 20 
rain, in essence leaving a surface bare of ]g molecules.) Thin sections of the cells 
treated  with  iodoacetamide  disclosed  the  presence  of  many  ferritin  mole- 
cules on the  surface and a  few small endocvtic vesicles containing  the  conju- 
gate. 
DISCUSSION 
Our studies have related the movement and interiorization  of surface com- 
plexes to  an  active metabolic process and  have given precise  information on 
the disposition of immune complexes on lymphocyte surfaces in metabolically 
inhibited cells.  We surmise that the combination of an antibody with an anti- 
gen on the cell surface can lead to different phenomena that are not necessarily 
interrelated: (a) the formation of single or multiple complexes occupying many 
zones on  the  cell  surface,  (b)  the  formation of a  single  compact mass at  one 
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The  requirements  for  multiple  aggregation  of  surface  complexes over  the 
entire surface and for cap formation do not run parallel,  and one does not per 
se result in the other.  Cap formation, apart from the factors analyzed earlier 
(bivalency of ligand,  sufficient  amount  of ligand,  sites  within  the  combining 
sites of the ligand), requires an actively metabolic cell.  A dead lymphocyte or 
one  whose  metabolism is  inhibited  will  not  develop caps.  Clearly,  inhibitors 
of glycolysis or of oxidative phosphorylation inhibited cap formation. 
Results  similar  to  these  with  selected  inhibitors  have  been  previously  re- 
ported  (1,  11).  Hence cap formation does not result from the passive conden- 
sation  of  the  antigen-antibody  complexes  into  one  tight  mass,  but  requires 
that  the  cell  in  some active way propel  the whole complex toward  a  zone of 
the surface, usually' opposite the Golgi region. It is most likely that this process 
takes place as a result of increased mobility of the cell  surface with or without 
concomitant cell  movement. Indeed,  the freeze-etch studies  on membranes in 
cells exhibiting caps disclosed what appeared to be undulations or waves of the 
whole cell  surface (5). Also,  lymphocytes in the process of capping adopted a 
pear shape, the nucleus at one zone being followed by a long tail at the end of 
which  the inmmne complex was observed  (5).  One  should  predict,  therefore, 
that cells that are slow or sluggish in movement would exhibit cap formation 
poorly; and to test this, studies are now being conducted in our laboratories. 
An  alternative explanation is that  the cells  are  not sluggish  in  movement, 
but rather that the surface movement that is required for cap formation must 
be  unidirectional  rather  than  random  (in  the  latter  case,  one  would  expect 
multiple complexes at different sites). Studies in progress do suggest differences 
in capping among cells that may not be explained entirely on the basis of the 
density  of  surface  molecules.  For  example,  histocompatibility  antigens  cap 
well  on  some  tumor  cells,  but  not  on  immature  sperm  cells. 2  (However, 
quantitative data on density of sites are not vet available.) 
One might have to reconcile the present hypothesis with the results obtained 
with  cvtochalasin  B,  in  which  no  clear  inhibition  of  capping  was  observed. 
The  effects of cytochalasin  B  on  cells  are  nmltiple  and  difficult  to  interpret 
(12,  13), but it has been observed that the drug inhibits cell movement in some 
systems.  There  is  no  indication  that  this  drug  necessarily  affects membrane 
movement per se. 
The  multiple  complexes that  formed  over the  entire  surface  membrane of 
metabolically inhibited lymphocytes were large, with clumps and thick strands 
of molecules; clearly, this formation of multiple surface complexes is unrelated 
to cell metabolic activity. The question arises whether the formation of caps in 
normal  cells  is  a  stepwise process involving,  first,  the  formation  of multiple 
complexes  disseminated  throughout,  which  then  coalesce  to  form  the  cap. 
Our previous studies on normal cells with the freeze-etching method,  the best 
method  available  to  date,  failed  to  disclose  any  readily discernible  two-step 688  MOVEMENT  OF  SURFACE  ANTIGENS.  III 
process in the mouse B lymphocytes. Loor, Forni, and Pernis (11)  do interpret 
their  fluorescence  data  as  suggesting  that  multiple  complexes  did  precede 
capping,  but  this  interpretation  is  limited  bv the  resolution  of the  immuno- 
fluorescence method. 
Clearly, in the case in which there is forraation of multiple small complexes, 
such as occurred in our past studv with small doses of anti-Ig on B lymphocytes 
or with antibodies to histocompatibility antigens on thymic cells,  the tendency 
was for these  complexes not  to  eventuate  into  a  single mass,  the cap (2).  In 
our  studies,  it  was only when  the  B  lymphocyte was covered with  sufficient 
antibody  to  form  a  lattice  covering  the  entire  cell  that  the  whole  complex 
readily moved into a single, tight,  cap zone. 
For  the  above reasons,  we  conclude  that  for formation of a  cap one must 
link together those cell surface antigens that are within the span of the  ligand 
forming  a  single,  large  lattice  over  the  entire  cell  membrane;  this  lattice  is 
then  rapidly  moved  by  the  cell.  The  reasons  whv  most  cells  having  small 
multiple  complexes do  not  end  up  having  a  single  complex  as  caps  are  not 
clear.  Perhaps  variations in  the  degree  of membrane movement with  forma- 
tion of small complexes, or competition between dissociation and interiorization 
of  the  complexes and  the  movement that  leads  to  cap,  or other factors that 
restrict the displacement of surface molecules are important. 
Inhibitors  of metabolism also  led  to  suppression  of  interiorization  and  ca- 
tabolism; and in this context, the metabolic needs for both capping and endo- 
cytosis appeared  similar.  Also,  the  formation  of multiple  complexes at  37°(; 
in inhibited  cells is in  agreement with current  concepts on  the fluidity' of the 
membrane lipid layer. However, generalizations on the metabolic requirements 
(or  lack  thereof)  for nmltiple  complex formation of other  receptors must  be 
made with  caution,  since  surface Ig molecules may have  properties different 
from those of other surface molecules. 
Finally,  a  brief comment on the methodology of studies  on geographic dis- 
tribution of surface molecules is warranted. Our studies clearly show that there 
was minimally, if any, significant aggregation of the anti-Ig-Ig lattice when B 
cells were incubated at 4°C even for as long as 4 h. Hence the method of incu- 
bating cells at this temperature for 1.2 h  with an appropriate ligand, if carried 
out under conditions of strict temperature control, appears to give a reasonable 
representation  of  the  true  surface  distribution  of molecules  at  a  given  time. 
Obviously,  we  are  aware  that  the  use of a  bivalent  ligand  may bring  closer 
receptors that  are within  the  span  of the  ligand,  although  the extent  of this 
approximation, if indeed present, is probably not enough to distort the general 
geographical picture. 
SUMMARY 
Spleen  lymphocytes were  studied  for  the  movement and  interiorization  of 
complexes of anti-Ig-surface Ig. The movement of  the  complex into  a  small, E.  R.  UNANUE, M.  J.  KARNOVSKY~ AND H.  D.  ENGERS  689 
compact zone of the  cell  membrane  (forming a  cap)  was  inhibited  by drugs 
that  inhibited  glycolysis  and  oxidative  phosphorylation,  but  not  by  drugs 
that affected protein  synthesis.  Dead lymphocytes did not form caps.  Freeze- 
etching  techniques  revealed  that  inhibited  lymphocytes showed formation  of 
multiple  small  complexes over the  entire  cell  surface.  Inhibitors  of glycolysis 
and of oxidative phosphorylation  also inhibited  the interiorization  and catabo- 
lism  of  radioiodinated  anti-Ig.  We  hypothesize  that  cross-linking  of  all  the 
surface  Ig  triggers  the  membrane  movements  that  are  required  to  pull  the 
lattice into one zone of the cell. 
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